These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8901155

  • 1. Bioavailability of estradiol from two transdermal patches.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Mar; 46(3):307-10. PubMed ID: 8901155
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

  • 3. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
    Rohr UD, Ehrly AM, Kuhl H.
    Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [Abstract] [Full Text] [Related]

  • 5. [Bioavailability of 17 beta-estradiol after transdermal administration--dependence on the patch system].
    Schmolling J, Kusche J, van der Ven H, Schander K.
    Zentralbl Gynakol; 1998 Aug; 120(3):121-5. PubMed ID: 9556902
    [Abstract] [Full Text] [Related]

  • 6. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women.
    Rohr UD, Nauert C, Stehle B.
    Maturitas; 1999 Sep 24; 33(1):45-58. PubMed ID: 10585173
    [Abstract] [Full Text] [Related]

  • 7. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC, Schmid K, Giacovelli G, Bonn M, Setnikar I, Wolff F, Genazzani AR.
    Arzneimittelforschung; 1999 Nov 24; 49(11):933-43. PubMed ID: 10604047
    [Abstract] [Full Text] [Related]

  • 8. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
    Rohr UD, Nauert C, Ehrly AM.
    Zentralbl Gynakol; 1995 Nov 24; 117(10):531-9. PubMed ID: 7491836
    [Abstract] [Full Text] [Related]

  • 9. Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patch.
    Setnikar I, Rovati LC, Santoro A, Guillaume M, Mignot A, Renoux A, Gualano V.
    Arzneimittelforschung; 1999 Aug 24; 49(8):708-15. PubMed ID: 10483519
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Thebault JJ, Guillaume M, Mignot A, Renoux A, Gualano V.
    Arzneimittelforschung; 1997 Jul 24; 47(7):859-65. PubMed ID: 9272245
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese.
    Chen GS, Zhang MY, Wang Q, Ye JC.
    Zhongguo Yao Li Xue Bao; 1996 Sep 24; 17(5):407-10. PubMed ID: 9863160
    [Abstract] [Full Text] [Related]

  • 12. Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara.
    Buch A, Shen L, Kelly S, Sahota R, Brezovic C, Bixler C, Powell J.
    Menopause; 1998 Sep 24; 5(2):107-12. PubMed ID: 9689205
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal women.
    Boyd RA, Zegarac EA, Eldon MA, Sedman AJ, Forgue ST.
    Biopharm Drug Dispos; 1996 Aug 24; 17(6):459-70. PubMed ID: 8866037
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability and pharmacokinetic profile of glyceryl trinitrate and of glyceryl dinitrates during application of a new glyceryl trinitrate transdermal patch.
    Santoro A, Rovati LC, Setnikar I, Caplain H, Gualano V.
    Arzneimittelforschung; 2000 Sep 24; 50(9):779-85. PubMed ID: 11050693
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
    Scott RT, Ross B, Anderson C, Archer DF.
    Obstet Gynecol; 1991 May 24; 77(5):758-64. PubMed ID: 2014092
    [Abstract] [Full Text] [Related]

  • 16. The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period.
    Haas S, Walsh B, Evans S, Krache M, Ravnikar V, Schiff I.
    Obstet Gynecol; 1988 May 24; 71(5):671-6. PubMed ID: 3357653
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
    Ko JC, Maxwell LK, Abbo LA, Weil AB.
    J Vet Pharmacol Ther; 2008 Aug 24; 31(4):359-67. PubMed ID: 18638297
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
    Zimmermann H, Koytchev R, Mayer O, Börner A, Mellinger U, Breitbarth H.
    Arzneimittelforschung; 1998 Sep 24; 48(9):941-7. PubMed ID: 9793623
    [Abstract] [Full Text] [Related]

  • 19. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.
    Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046
    [Abstract] [Full Text] [Related]

  • 20. Bioavailability of estradiol from a new matrix and a conventional reservoir-type transdermal therapeutic system.
    Müller P, Botta L, Ezzet F.
    Eur J Clin Pharmacol; 1996 Jun 20; 51(3-4):327-30. PubMed ID: 9010707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.